| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $410K | +12.9K | +59.9% | $31.76 | 34.4K | 02 May 2022 | Direct | F1 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Sale | -$591K | -12.9K | -37.46% | $45.79 | 21.5K | 02 May 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -12.9K | -100% | $0.00* | 0 | 02 May 2022 | Ordinary Shares, par value EUR 0.01 per share | 12.9K | $31.76 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Includes 2,547 unvested restricted securities that are not subject to performance conditions. |
| F2 | Reflects the sale of an aggregate of 12,900 shares of common stock on May 2, 2022, at the weighted average sales price of $45.7913. The prices for these sales range from $45.64 to $45.93. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | These options were set to expire May 25, 2022. |
| F4 | The option grant became exercisable over four years at 25% per year, beginning on the first anniversary date of May 25, 2013. |